You are here: Home » News-CM » Companies » Results
Business Standard

Sandu Pharmaceuticals standalone net profit declines 3.13% in the June 2019 quarter

Capital Market 

Sales rise 11.16% to Rs 12.35 crore

Net profit of Sandu Pharmaceuticals declined 3.13% to Rs 0.31 crore in the quarter ended June 2019 as against Rs 0.32 crore during the previous quarter ended June 2018. Sales rose 11.16% to Rs 12.35 crore in the quarter ended June 2019 as against Rs 11.11 crore during the previous quarter ended June 2018. ParticularsQuarter EndedJun. 2019Jun. 2018% Var.Sales12.3511.11 11 OPM %3.325.13 -PBDT0.410.51 -20 PBT0.270.35 -23 NP0.310.32 -3

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, August 14 2019. 15:53 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU